Influenza hemagglutination inhibiting activity in respiratory mucus from horses with chronic obstructive pulmonary disorders (heaves syndrome).

The researchers conducted a study to understand the level of influenza A hemagglutination inhibitors in the mucus of horses suffering from chronic obstructive pulmonary disease (COPD), often referred to as heaves syndrome. They found high levels of these inhibitors in mucus samples from the sick horses.

Research methodology

• The investigators collected mucus samples from the lower trachea of 53 horses diagnosed with chronic obstructive pulmonary disease (COPD), categorised under heaves syndrome.
• 24 clinically normal horses also provided mucus samples for comparison.
• They also collected serum samples from 35 of the horses with COPD in addition to those from the 24 clinically normal horses.

Testing procedures and results

• The collected mucus and serum samples were tested for the inhibition of hemagglutination, a process that occurs when red blood cells (erythrocytes) or other similar types of cells aggregate or clump together.
• The samples were tested against two specific strains of equine influenza viruses, namely, influenza A equine 1 and influenza A equine 2.
• The findings indicate high levels of hemagglutination inhibiting activity, specifically against influenza A equine 1, in the mucus samples collected from horses diagnosed with COPD.
• Such high levels of inhibitors suggest the body is attempting to prevent the clumping or aggregation of cells, which is caused by the influenza virus. This may indicate a heightened immune response to the virus in horses suffering from COPD, more so than in those that are clinically normal.

Implications of the research

• If such high levels of inhibitors are consistently found among horses with COPD, these findings could potentially be used as a biomarker for diagnosing COPD in horses.
• The findings could also significantly affect how COPD is treated or managed in horses. This is because if the body’s natural production of hemagglutination inhibitors can be boosted or supported, it may reduce the severity of the disease or perhaps help the horses to recover quicker.
• The research may also be expanded to other species or conditions, offering the potential for advancements and insights in broader fields of virology, immunology, and respiratory medicine.